Melinda L. Yushak
Advanced in Liposarcoma

Dr. Melinda L. Yushak

Oncology
Emory health
Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
17 Years of Experience
Advanced in Liposarcoma
Emory health
Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Melinda Yushak is an Oncologist in Atlanta, Georgia. Dr. Yushak has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Liposarcoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Undifferentiated Pleomorphic Sarcoma, and Mesenchymoma.

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Liposarcoma.

Graduate Institution
University Of Vermont, 2009.0
Residency
Beth Israel Deaconess Medical Center
Specialties
Oncology
Licenses
Internal Medicine in MA
Board Certifications
American Board Of Internal Medicine, 2016
Fellowships
Yale New Haven Hospital
Hospital Affiliations
Emory University Hospital Midtown
Emory Johns Creek Hospital
Emory University Hospital
Saint Joseph's Hospital Of Atlanta, Inc
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, Atlanta, GA 30322
Call: 404-778-1900

Additional Areas of Focus

Dr. Yushak has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Enrollment Status: Recruiting
Publish Date: October 30, 2025
Intervention Type: Procedure, Biological
Study Drug: Nivolumab
Study Phase: Phase 1
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Other, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination With Dual BRAF/MEK Inhibition in Patients With BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy
Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination With Dual BRAF/MEK Inhibition in Patients With BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2025
Intervention Type: Procedure, Drug
Study Drugs: Dabrafenib Mesylate, Tazemetostat Hydrobromide, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 1/Phase 2
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 01, 2025
Intervention Type: Biological, Drug
Study Drugs: IMCgp100, Dacarbazine, Ipilimumab, Pembrolizumab
Study Phase: Phase 2
Master Protocol to Assess the Safety and Recommended Phase 2 Dose of Next Generations of Autologous Enhanced NY-ESO-1/ LAGE-1a TCR Engineered T-cells, Alone or in Combination With Other Agents, in Participants With Advanced Tumors
Master Protocol to Assess the Safety and Recommended Phase 2 Dose of Next Generations of Autologous Enhanced NY-ESO-1/ LAGE-1a TCR Engineered T-cells, Alone or in Combination With Other Agents, in Participants With Advanced Tumors
Enrollment Status: Terminated
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drugs: GSK3901961, GSK3845097, Fludarabine, Cyclophosphamide
Study Phase: Phase 1
A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma
A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Combination product
Study Drug: Melphalan/Hepatic Device System
Study Phase: Phase 3
View 6 Less Clinical Trials

23 Total Publications

The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
Journal: Urology case reports
Published: August 15, 2024
View All 23 Publications
Similar Doctors
William L. Read
Distinguished in Liposarcoma
Dr. William L. Read
Oncology
Distinguished in Liposarcoma
Dr. William L. Read
Oncology

Winship Cancer Institute At Emory Midtown

36 Linden Avenue Northeast, Fl14, 
Atlanta, GA 
 (3.4 miles away)
404-778-1900
Experience:
30+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Read is an Oncologist in Atlanta, Georgia. Dr. Read has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Liposarcoma.

Felicia Williams
Distinguished in Liposarcoma
Felicia Williams, NP
Oncology
Distinguished in Liposarcoma
Felicia Williams, NP
Oncology

Winship Cancer Institute At Emory Midtown

36 Linden Avenue Northeast, Fl14, 
Atlanta, GA 
 (3.4 miles away)
404-778-1900
Languages Spoken:
English
See accepted insurances

Felicia Williams is an Oncologist in Atlanta, Georgia. Dr. Williams is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. Her top areas of expertise are Alveolar Soft Part Sarcoma, Bone Tumor, Mesenchymoma, and Undifferentiated Pleomorphic Sarcoma.

Distinguished in Liposarcoma
Dr. Kamal N. Ummed
Hematology Oncology | Hematology | Oncology
Distinguished in Liposarcoma
Dr. Kamal N. Ummed
Hematology Oncology | Hematology | Oncology

Nsh Cancer Institute Professional Services G LLC

1045 Southcrest Dr, Suite 200, 
Stockbridge, GA 
 (17.6 miles away)
678-289-0549
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Kamal Ummed is a Hematologist Oncology specialist and a Hematologist in Stockbridge, Georgia. Dr. Ummed is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Bone Tumor, Liposarcoma, Rhabdomyosarcoma Embryonal, and Undifferentiated Pleomorphic Sarcoma. Dr. Ummed is currently accepting new patients.

VIEW MORE LIPOSARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yushak's expertise for a condition
ConditionClose
  • Elite
  • Melanoma
    Dr. Yushak is
    Elite
    . Learn about Melanoma.
    See more Melanoma experts
  • Distinguished
  • Melanoma of the Eye
    Dr. Yushak is
    Distinguished
    . Learn about Melanoma of the Eye.
    See more Melanoma of the Eye experts
  • Merkel Cell Carcinoma
    Dr. Yushak is
    Distinguished
    . Learn about Merkel Cell Carcinoma.
    See more Merkel Cell Carcinoma experts
  • Mesenchymoma
    Dr. Yushak is
    Distinguished
    . Learn about Mesenchymoma.
    See more Mesenchymoma experts
  • Undifferentiated Pleomorphic Sarcoma
    Dr. Yushak is
    Distinguished
    . Learn about Undifferentiated Pleomorphic Sarcoma.
    See more Undifferentiated Pleomorphic Sarcoma experts
  • Advanced
  • Adult Soft Tissue Sarcoma
    Dr. Yushak is
    Advanced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Alveolar Soft Part Sarcoma
    Dr. Yushak is
    Advanced
    . Learn about Alveolar Soft Part Sarcoma.
    See more Alveolar Soft Part Sarcoma experts
  • Angiosarcoma of the Scalp
    Dr. Yushak is
    Advanced
    . Learn about Angiosarcoma of the Scalp.
    See more Angiosarcoma of the Scalp experts
  • Bone Tumor
    Dr. Yushak is
    Advanced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Epithelioid Sarcoma
    Dr. Yushak is
    Advanced
    . Learn about Epithelioid Sarcoma.
    See more Epithelioid Sarcoma experts
  • Fibrosarcoma
    Dr. Yushak is
    Advanced
    . Learn about Fibrosarcoma.
    See more Fibrosarcoma experts
View All 17 Advanced Conditions
  • Experienced
  • Adenoid Cystic Carcinoma
    Dr. Yushak is
    Experienced
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • Anal Cancer
    Dr. Yushak is
    Experienced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Angiosarcoma
    Dr. Yushak is
    Experienced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Brain Tumor
    Dr. Yushak is
    Experienced
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Chondrosarcoma
    Dr. Yushak is
    Experienced
    . Learn about Chondrosarcoma.
    See more Chondrosarcoma experts
  • Chordoma
    Dr. Yushak is
    Experienced
    . Learn about Chordoma.
    See more Chordoma experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.